Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 21 | 2022 | 5097 | 0.920 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2019 | 256 | 0.850 |
Why?
|
| Condoms, Female | 6 | 2020 | 41 | 0.830 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2020 | 262 | 0.820 |
Why?
|
| Counseling | 3 | 2018 | 143 | 0.700 |
Why?
|
| Sexual Partners | 7 | 2020 | 215 | 0.680 |
Why?
|
| Reproductive Health Services | 5 | 2018 | 66 | 0.650 |
Why?
|
| Sex Workers | 5 | 2018 | 116 | 0.610 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 43 | 0.590 |
Why?
|
| Sexual Behavior | 8 | 2020 | 320 | 0.580 |
Why?
|
| Contraceptive Devices, Female | 3 | 2020 | 30 | 0.490 |
Why?
|
| Adult | 24 | 2022 | 5913 | 0.440 |
Why?
|
| Condoms | 4 | 2020 | 88 | 0.430 |
Why?
|
| Female | 28 | 2022 | 9103 | 0.420 |
Why?
|
| Safe Sex | 3 | 2019 | 68 | 0.400 |
Why?
|
| Humans | 30 | 2022 | 14537 | 0.360 |
Why?
|
| Equipment Failure | 5 | 2019 | 13 | 0.350 |
Why?
|
| South Africa | 22 | 2022 | 7596 | 0.340 |
Why?
|
| Risk-Taking | 4 | 2020 | 121 | 0.340 |
Why?
|
| Health Personnel | 5 | 2021 | 231 | 0.330 |
Why?
|
| Cross-Over Studies | 8 | 2020 | 40 | 0.280 |
Why?
|
| Contraception, Barrier | 2 | 2018 | 5 | 0.270 |
Why?
|
| Male | 14 | 2021 | 6754 | 0.270 |
Why?
|
| Choice Behavior | 2 | 2016 | 16 | 0.260 |
Why?
|
| Young Adult | 12 | 2020 | 2498 | 0.260 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 106 | 0.260 |
Why?
|
| Sex Counseling | 2 | 2016 | 9 | 0.250 |
Why?
|
| Menstrual Hygiene Products | 2 | 2015 | 8 | 0.240 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 14 | 0.240 |
Why?
|
| Fertilization | 2 | 2015 | 22 | 0.240 |
Why?
|
| Intention | 2 | 2015 | 23 | 0.240 |
Why?
|
| Focus Groups | 4 | 2018 | 196 | 0.230 |
Why?
|
| Equipment Design | 3 | 2019 | 27 | 0.220 |
Why?
|
| HIV Seropositivity | 4 | 2020 | 265 | 0.220 |
Why?
|
| Reproductive Health | 2 | 2021 | 51 | 0.220 |
Why?
|
| Patient Satisfaction | 4 | 2019 | 43 | 0.220 |
Why?
|
| Pregnancy | 9 | 2021 | 1862 | 0.210 |
Why?
|
| Consumer Behavior | 2 | 2019 | 20 | 0.210 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 1422 | 0.200 |
Why?
|
| Intimate Partner Violence | 1 | 2022 | 55 | 0.200 |
Why?
|
| Uganda | 2 | 2022 | 197 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2016 | 472 | 0.190 |
Why?
|
| Adolescent | 9 | 2022 | 2985 | 0.180 |
Why?
|
| Silicones | 1 | 2020 | 2 | 0.180 |
Why?
|
| Pyrimidines | 1 | 2020 | 32 | 0.170 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2018 | 103 | 0.170 |
Why?
|
| Men | 1 | 2020 | 15 | 0.170 |
Why?
|
| Communication Barriers | 2 | 2020 | 10 | 0.160 |
Why?
|
| Middle Aged | 8 | 2020 | 3601 | 0.150 |
Why?
|
| HIV | 2 | 2018 | 380 | 0.150 |
Why?
|
| Efficiency | 1 | 1998 | 3 | 0.150 |
Why?
|
| Economics | 1 | 1998 | 5 | 0.150 |
Why?
|
| Employment | 1 | 1998 | 27 | 0.150 |
Why?
|
| Heterosexuality | 1 | 2018 | 30 | 0.150 |
Why?
|
| Morbidity | 1 | 1998 | 37 | 0.150 |
Why?
|
| Diaphragm | 1 | 2018 | 2 | 0.150 |
Why?
|
| Physicians | 1 | 2018 | 31 | 0.150 |
Why?
|
| Commerce | 1 | 1998 | 22 | 0.150 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2018 | 24 | 0.150 |
Why?
|
| Pre-Exposure Prophylaxis | 2 | 2018 | 196 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 57 | 0.140 |
Why?
|
| Community Health Workers | 1 | 2018 | 66 | 0.140 |
Why?
|
| Circumcision, Male | 1 | 2018 | 99 | 0.140 |
Why?
|
| Mozambique | 4 | 2017 | 55 | 0.130 |
Why?
|
| Self Administration | 1 | 2016 | 5 | 0.130 |
Why?
|
| Anti-HIV Agents | 2 | 2022 | 1324 | 0.130 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 187 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 252 | 0.130 |
Why?
|
| AIDS Serodiagnosis | 1 | 2016 | 44 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2016 | 529 | 0.130 |
Why?
|
| Health Behavior | 1 | 2016 | 79 | 0.130 |
Why?
|
| Menstruation | 1 | 2015 | 10 | 0.120 |
Why?
|
| Absorbent Pads | 1 | 2015 | 2 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 57 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 563 | 0.120 |
Why?
|
| Reproduction | 1 | 2014 | 25 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 48 | 0.120 |
Why?
|
| Racism | 1 | 2014 | 4 | 0.110 |
Why?
|
| Internet | 1 | 2014 | 12 | 0.110 |
Why?
|
| Social Support | 1 | 2014 | 77 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 43 | 0.110 |
Why?
|
| Social Stigma | 1 | 2014 | 80 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 280 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 551 | 0.110 |
Why?
|
| India | 3 | 2017 | 62 | 0.100 |
Why?
|
| Kenya | 3 | 2017 | 183 | 0.100 |
Why?
|
| Contraception | 3 | 2017 | 90 | 0.090 |
Why?
|
| Motivation | 3 | 2016 | 59 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2022 | 889 | 0.070 |
Why?
|
| Cities | 2 | 2018 | 37 | 0.070 |
Why?
|
| Africa South of the Sahara | 2 | 2018 | 353 | 0.070 |
Why?
|
| Women's Health Services | 2 | 2018 | 12 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2019 | 203 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 370 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2019 | 321 | 0.060 |
Why?
|
| Government Programs | 1 | 2022 | 30 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 244 | 0.050 |
Why?
|
| Fertility | 1 | 2021 | 22 | 0.050 |
Why?
|
| United States | 1 | 2020 | 132 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2022 | 799 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 179 | 0.040 |
Why?
|
| Disease | 1 | 1998 | 12 | 0.040 |
Why?
|
| Botswana | 1 | 1998 | 24 | 0.040 |
Why?
|
| Coitus | 1 | 2018 | 15 | 0.040 |
Why?
|
| Africa, Southern | 1 | 1998 | 91 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2018 | 50 | 0.040 |
Why?
|
| Virus Diseases | 1 | 1998 | 55 | 0.040 |
Why?
|
| Financing, Personal | 1 | 2017 | 12 | 0.030 |
Why?
|
| Africa | 1 | 1998 | 376 | 0.030 |
Why?
|
| Pregnancy, Unwanted | 1 | 2016 | 9 | 0.030 |
Why?
|
| Home Nursing | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2016 | 29 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 127 | 0.030 |
Why?
|
| Contraception Behavior | 1 | 2016 | 54 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 125 | 0.030 |
Why?
|
| Developing Countries | 1 | 1998 | 400 | 0.030 |
Why?
|
| Child | 1 | 2021 | 2242 | 0.030 |
Why?
|
| Learning Curve | 1 | 2014 | 2 | 0.030 |
Why?
|
| Materials Testing | 1 | 2014 | 16 | 0.030 |
Why?
|
| Self Report | 1 | 2015 | 114 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2014 | 7 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 56 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 14 | 0.030 |
Why?
|
| Directive Counseling | 1 | 2014 | 15 | 0.030 |
Why?
|
| Posters as Topic | 1 | 2014 | 1 | 0.030 |
Why?
|
| Social Identification | 1 | 2014 | 4 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 35 | 0.030 |
Why?
|
| Attitude | 1 | 2014 | 12 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 254 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2014 | 120 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2014 | 225 | 0.030 |
Why?
|
| China | 1 | 2013 | 21 | 0.030 |
Why?
|
| Students | 1 | 2014 | 50 | 0.030 |
Why?
|
| Violence | 1 | 2014 | 68 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 656 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 472 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1192 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 1475 | 0.020 |
Why?
|
| HIV-1 | 1 | 2016 | 1260 | 0.020 |
Why?
|